Partnership
We are a pioneering pharmaceutical venture developing innovative immunosuppressants to overcome complex immunological disorders. Our mission is to restore immune balance, enabling healthier lives and building a more resilient society.
Chief Technical Officer
AT-31 BIO Inc.
Daegu, South Korea
Leading the paradigm shift in immunology. AT-31 BIO delivers breakthrough solutions for complex immune disorders through advanced next-generation immunosuppressive therapies.
I am a Molecular Immuno-Cell Biologist with experience developing cancer cell vaccines at the Johns Hopkins University Oncology Center. Currently, at AT-31 BIO Inc., I focus on developing treatments for autoimmune diseases, including Sjögren’s syndrome, dry eye, inflammatory bowel disease, and atopic dermatitis. I have published 95 papers and hold 28 patents.
Education and Career
Ph. D in Microbiology, Kyungpook National Uni
Johns Hopkins University, USA (Postdoctoral fellowship)
Former R&D head at Astrogen Inc., South Korea
Co-development Scientific Committee at Kyungpook Uni Hospital
Partnership
We are a pioneering pharmaceutical venture developing innovative immunosuppressants to overcome complex immunological disorders. Our mission is to restore immune balance, enabling healthier lives and building a more resilient society.